What these medicines do
Anticoagulants interfere with the clotting process to help prevent harmful clots from forming or growing. They are distinct from antiplatelet medicines, which act on platelets. The everyday phrase “blood thinner” does not describe a physical thinning of the blood.
Different groups, different considerations
Common groups include vitamin K antagonists such as warfarin; direct oral anticoagulants, including dabigatran and factor Xa inhibitors; and injectable agents such as heparins. Administration, interactions and monitoring differ between groups.
Begin with the clinical question
Selection is tied to the indication and patient context. A medicine used in one setting is not automatically suitable in another. Before turning to a dose or pathway, establish the clinical question and consult the current indication-specific reference.
The key idea
Drug class is a useful introduction; individual treatment decisions require much more context.
Sources & further reading
External references are provided for education. Their inclusion does not imply endorsement of Anticoag360+.
Educational overview for healthcare professionals. Use the current source guidance, local protocols and professional judgement for individual decisions. These articles are not patient-specific treatment instructions.
Prepared for Anticoag360+’s educational website. No independent clinical peer review is claimed.